Clinical Trial: Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus Relief

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07580911) titled 'Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus Relief' on April 29.

Brief Summary: This is a prospective, single-arm, open-label, pilot clinical study to evaluate the efficacy and safety of topical 10% high-concentration 35 kDa hyaluronan (HA35) gel for ultra-rapid relief of moderate-to-severe skin pruritus from diverse etiologies (eczema, neurodermatitis, insect bites, urticaria, postoperative wound itch). Eligible participants will receive a single topical application of HA35 gel. The primary objective is to assess pruritus relief at 10 seconds, 45 minutes, 8 hours, 12 hours, and 24 hours post-application. Safety and...